The biotechnology company said in its statement to the ASX that the US Food and Drug Administration (FDA) had granted ...

Positive Phase 3 HERIZON-GEA-01 results for Ziihera (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal adenocarcinoma (GEA) presented at ASCO GI Up to $440.0 million in milestone ...

Stoke Therapeutics and the FDA were unable to reach agreement on an expedited submission for the company’s severe epilepsy ...

Genetic treatments could be the key to unlocking some rare diseases. But bringing these medicines to patients involves ...

This clinical-stage biotech specializing in antibody therapeutics reported a notable insider sale amid ongoing development and partnerships.

Albuquerque-based EquiSeq is a biotech company developing DNA tests for inherited muscle diseases, like muscle integrity ...

This biotech innovator in antibody therapies for inflammatory bowel disease reported a notable insider sale, according to a recent SEC filing.

From lab space and coffee bars to jobs and long-term returns, mid-tier life sciences hubs may be better positioned than the biggest biotech boomtowns.

Alliance brings together complementary strengths in commercialization strategy, cross-functional launch readiness, ...

The team brings a strong balance of scientific and commercial expertise, has built a unique data foundation with a ...

BURTON, MI, UNITED STATES, January 9, 2026 /EINPresswire.com/ -- Javelin Sciences, a pioneering certified biotechnology ...

Under the terms of the collaboration, Iktos will apply its generative AI and AI-orchestrated robotics platform to design, ...